SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3l6y'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1B2I_A_AMHA84_1
(PROTEIN
(PLASMINOGEN))
3l6y CATENIN DELTA-1
(Homo
sapiens)
4 / 7 TYR A 650
GLU A 593
PHE A 654
ARG A 599
None
1.26A 1b2iA-3l6yA:
undetectable
1b2iA-3l6yA:
8.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1I18_B_RBFB99_1
(RIBOFLAVIN SYNTHASE
ALPHA CHAIN)
3l6y CATENIN DELTA-1
(Homo
sapiens)
5 / 10 THR A 498
LEU A 527
THR A 469
ILE A 472
THR A 473
None
1.24A 1i18A-3l6yA:
undetectable
1i18B-3l6yA:
undetectable
1i18A-3l6yA:
11.93
1i18B-3l6yA:
11.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CC8_A_RBFA1067_1
(VNG1446H)
3l6y CATENIN DELTA-1
(Homo
sapiens)
3 / 3 PHE A 654
VAL A 590
TRP A 690
None
0.69A 2cc8A-3l6yA:
undetectable
2cc8A-3l6yA:
8.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CCB_A_RBFA1067_1
(VNG1446H)
3l6y CATENIN DELTA-1
(Homo
sapiens)
3 / 3 PHE A 654
VAL A 590
TRP A 690
None
0.67A 2ccbA-3l6yA:
undetectable
2ccbA-3l6yA:
8.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CD2_A_FOLA307_0
(DIHYDROFOLATE
REDUCTASE)
3l6y CATENIN DELTA-1
(Homo
sapiens)
5 / 12 ILE A 503
LEU A 494
THR A 530
LEU A 558
ILE A 502
None
1.01A 2cd2A-3l6yA:
undetectable
2cd2A-3l6yA:
16.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DQY_A_CHDA1_0
(LIVER
CARBOXYLESTERASE 1)
3l6y CATENIN DELTA-1
(Homo
sapiens)
4 / 5 TRP A 477
GLY A 438
LYS A 444
LEU A 479
None
1.41A 2dqyA-3l6yA:
undetectable
2dqyA-3l6yA:
21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q63_A_1UNA1001_2
(PROTEASE RETROPEPSIN)
3l6y CATENIN DELTA-1
(Homo
sapiens)
3 / 3 ARG A 729
ASN A 715
THR A 768
None
0.87A 2q63A-3l6yA:
undetectable
2q63A-3l6yA:
9.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VX9_A_RBFA1064_1
(DODECIN)
3l6y CATENIN DELTA-1
(Homo
sapiens)
3 / 3 PHE A 654
VAL A 590
TRP A 690
None
0.69A 2vx9A-3l6yA:
undetectable
2vx9A-3l6yA:
8.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YFB_B_ACTB501_0
(METHYL-ACCEPTING
CHEMOTAXIS
TRANSDUCER)
3l6y CATENIN DELTA-1
(Homo
sapiens)
4 / 6 ASP A 440
VAL A 404
ARG A 405
ILE A 410
None
1.21A 2yfbB-3l6yA:
undetectable
2yfbB-3l6yA:
19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3D9L_A_ACTA501_0
(CTD-PEPTIDE
RNA-BINDING PROTEIN
16)
3l6y CATENIN DELTA-1
(Homo
sapiens)
4 / 5 PRO A 656
ILE A 696
TYR A 692
TYR A 695
None
1.32A 3d9lA-3l6yA:
2.8
3d9lY-3l6yA:
undetectable
3d9lA-3l6yA:
13.30
3d9lY-3l6yA:
1.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3P2K_C_SAMC6735_0
(16S RRNA METHYLASE)
3l6y CATENIN DELTA-1
(Homo
sapiens)
5 / 12 GLY A 474
ASN A 529
ALA A 463
LEU A 432
LEU A 468
None
1.04A 3p2kC-3l6yA:
undetectable
3p2kC-3l6yA:
17.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SO9_A_017A100_2
(HIV-1 PROTEASE)
3l6y CATENIN DELTA-1
(Homo
sapiens)
5 / 12 LEU A 527
ASP A 465
ASP A 467
THR A 530
VAL A 526
None
0.96A 3so9B-3l6yA:
undetectable
3so9B-3l6yA:
12.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4GBO_B_CUB301_0
(E7)
3l6y CATENIN DELTA-1
(Homo
sapiens)
4 / 5 ALA A 687
HIS A 591
GLN A 589
TYR A 588
None
1.36A 4gboB-3l6yA:
undetectable
4gboB-3l6yA:
15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L1W_A_STRA402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
3l6y CATENIN DELTA-1
(Homo
sapiens)
4 / 7 VAL A 562
ILE A 561
LEU A 548
LEU A 554
None
0.88A 4l1wA-3l6yA:
undetectable
4l1wA-3l6yA:
19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MK4_A_CHDA503_0
(FERROCHELATASE,
MITOCHONDRIAL)
3l6y CATENIN DELTA-1
(Homo
sapiens)
5 / 10 LEU A 479
LEU A 476
LEU A 460
ILE A 485
THR A 498
None
1.35A 4mk4A-3l6yA:
undetectable
4mk4A-3l6yA:
20.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKV_D_AERD601_2
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)
3l6y CATENIN DELTA-1
(Homo
sapiens)
4 / 5 GLY A 553
ASP A 556
GLU A 550
VAL A 590
None
1.15A 4nkvD-3l6yA:
undetectable
4nkvD-3l6yA:
22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O1Z_A_MXMA807_1
(PROSTAGLANDIN G/H
SYNTHASE 1)
3l6y CATENIN DELTA-1
(Homo
sapiens)
5 / 12 LEU A 666
ILE A 682
GLY A 680
ALA A 681
LEU A 583
None
0.98A 4o1zA-3l6yA:
0.9
4o1zA-3l6yA:
22.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XO7_A_ASDA402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
3l6y CATENIN DELTA-1
(Homo
sapiens)
4 / 7 VAL A 562
ILE A 561
LEU A 548
LEU A 554
None
1.00A 4xo7A-3l6yA:
undetectable
4xo7A-3l6yA:
19.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I1N_F_DVAF9_0
(D-VILLIN HEADPIECE
SUBDOMAIN
VILLIN-1)
3l6y CATENIN DELTA-1
(Homo
sapiens)
3 / 3 ALA A 727
ASN A 730
LEU A 731
None
0.45A 5i1nC-3l6yA:
undetectable
5i1nC-3l6yA:
4.99